MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Logistics Development buys Alliance Pharma shares for £6.8 million

ALN

Logistics Development Group PLC on Tuesday said it bought further shares in Alliance Pharma PLC, spending £6.8 million.

Logistics Development is a London-based investment company, while Alliance Pharma is a Chippenham, England-based distributor of consumer healthcare brands and prescription medicines.

Logistics Development purchased an additional 10.2 million shares in Alliance Pharma at an average price of 66.83 pence per share, taking its overall stake to 29.0 million Alliance Pharma shares, or 5.4% of share capital.

Shares in Alliance Pharma were up 3.2% to 59.42p each in London on Tuesday late morning, while Logistics Development shares were down 1.3% to 14.80p.

Also on Tuesday, Alliance Pharma reported 2022 pretax profit plunged 71% to £5.2 million from £18.2 million in 2021, despite revenue ticking up 1.4% to £172.0 million from £169.6 million.

This was largely due to impairment of goodwill and intangible assets trebling to £18.2 million from £6.2 million.

Alliance Pharma declared a final dividend of 1.184p, up 5.0% from 1.128p a year earlier, taking its total 2022 dividend to 1.776p, up 5.0% from 1.691p in 2021.

Looking ahead, Alliance Pharma said: ‘Our portfolio of Other Consumer brands is expected to deliver high single digit revenue growth, substantially ahead of the broader consumer healthcare market.’

Copyright 2023 Alliance News Ltd. All Rights Reserved.